Home » Topics » Disease categories and therapies » Infection

Infection
RSS

SmithKline Beecham's Famvir receives U.K. approval for new indication

May 21, 1997

Fujisawa describes new cephems

May 21, 1997

Xoma issued U.S. patent for antifungal uses of BPI-derived products

May 20, 1997

Aronex extends clinical trials with Nyotran

May 20, 1997

Abelcet earns regulatory approval in Switzerland

May 16, 1997

SmithKline Beecham and LG Chemical sign agreement for new antibiotic

May 14, 1997

Promising results reported on new complex carbohydrate antifungal compound

May 14, 1997

Bristol-Myers Squibb launches Vagistat-1 as OTC in the U.S.

May 13, 1997

Penederm receives approval for butenafine in Canada

May 12, 1997

Wakunaga prepares novel antibacterial agents

May 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...